Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bidlingmaier

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|June 11, 2015
Unaltered ratio of circulating levels of growth hormone/GH isoforms in adults with Prader-Willi syndrome after GHRH plus arginine administrationA E Rigamonti, G Grugni, N Marazzi, et al.
The Journal of Clinical Endocrinology and Metabolism|July 10, 2001
Lowering total plasma insulin-like growth factor I concentrations by way of a novel, potent, and selective growth hormone (GH) receptor antagonist, pegvisomant (B2036-peg), augments the amplitude of GH secretory bursts and elevates basal/nonpulsatile GH release in healthy women and menJ D Veldhuis, M Bidlingmaier, S M Anderson, et al.
European Journal of Medical Research|May 16, 2002
The tumour necrosis factor-alpha induced vascular permeability is associated with a reduction of VE-cadherin expressionS Hofmann, H Grasberger, P Jung, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|September 3, 2003
Serum leptin monitoring in anorectic patients during refeeding therapyS Lob, J Pickel, M Bidlingmaier, et al.
Journal of Endocrinological Investigation|July 4, 2001
Post-prandial decrease of circulating human ghrelin levelsM Tschöp, R Wawarta, R L Riepl, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|July 6, 2010
The acute effect of a single application of cabergoline on endogenous GH levels in patients with acromegaly on pegvisomant treatmentJ Roemmler, B Steffin, B Gutt, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|March 11, 2010
Salivary aldosterone as a diagnostic aid in primary aldosteronismJ Manolopoulou, S Gerum, P Mulatero, et al.
Hormone Research|May 15, 2002
Differential regulation of insulin-like growth factor-(IGF) I and IGF-binding protein (IGFBP) secretion by human peripheral blood mononuclear cellsC J Auernhammer, C Fottner, D Engelhardt, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|April 25, 2013
Assay characteristics influence the aldosterone to renin ratio as a screening tool for primary aldosteronism: results of the German Conn's registryE Fischer, S Reuschl, M Quinkler, et al.
European Journal of Endocrinology|May 5, 2009
Successful use of weekly pegvisomant administration in patients with acromegalyC E Higham, J D J Thomas, M Bidlingmaier, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|June 11, 2015
Unaltered ratio of circulating levels of growth hormone/GH isoforms in adults with Prader-Willi syndrome after GHRH plus arginine administrationA E Rigamonti, G Grugni, N Marazzi, et al.
The Journal of Clinical Endocrinology and Metabolism|July 10, 2001
Lowering total plasma insulin-like growth factor I concentrations by way of a novel, potent, and selective growth hormone (GH) receptor antagonist, pegvisomant (B2036-peg), augments the amplitude of GH secretory bursts and elevates basal/nonpulsatile GH release in healthy women and menJ D Veldhuis, M Bidlingmaier, S M Anderson, et al.
European Journal of Medical Research|May 16, 2002
The tumour necrosis factor-alpha induced vascular permeability is associated with a reduction of VE-cadherin expressionS Hofmann, H Grasberger, P Jung, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|September 3, 2003
Serum leptin monitoring in anorectic patients during refeeding therapyS Lob, J Pickel, M Bidlingmaier, et al.
Journal of Endocrinological Investigation|July 4, 2001
Post-prandial decrease of circulating human ghrelin levelsM Tschöp, R Wawarta, R L Riepl, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|July 6, 2010
The acute effect of a single application of cabergoline on endogenous GH levels in patients with acromegaly on pegvisomant treatmentJ Roemmler, B Steffin, B Gutt, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|March 11, 2010
Salivary aldosterone as a diagnostic aid in primary aldosteronismJ Manolopoulou, S Gerum, P Mulatero, et al.
Hormone Research|May 15, 2002
Differential regulation of insulin-like growth factor-(IGF) I and IGF-binding protein (IGFBP) secretion by human peripheral blood mononuclear cellsC J Auernhammer, C Fottner, D Engelhardt, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|April 25, 2013
Assay characteristics influence the aldosterone to renin ratio as a screening tool for primary aldosteronism: results of the German Conn's registryE Fischer, S Reuschl, M Quinkler, et al.
European Journal of Endocrinology|May 5, 2009
Successful use of weekly pegvisomant administration in patients with acromegalyC E Higham, J D J Thomas, M Bidlingmaier, et al.
Pageof 9